secwatch.observer — SEC 8-K summary
======================================

Issuer:     BriaCell Therapeutics Corp. (BCTX)
CIK:        0001610820
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001493152-24-049999
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BriaCell closes $5.55M public offering of 7.4M units at $0.75/unit
------------------------------------------------------------------

- Underwritten public offering of 7,400,000 units closed Dec 13, 2024; gross proceeds $5.55M.
- Each unit: 1 common share + 1 warrant exercisable at $0.9375 for 5 years.
- Underwriter ThinkEquity received 370,000 representative's warrants on same terms.
- Net proceeds to be used for working capital, general corporate purposes, and business advancement.
- Offering made under effective shelf registration statement (S-3 No. 333-276650).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224049999/0001493152-24-049999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610820/000149315224049999/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-049999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer